Explorer les evidences

Palier Gold : evidences validées mécaniquement, avec leur source primaire.

2 070 evidences · page 9 / 83

10 000 000 childrenIn Nigeria, more than 10 million children are exposed to seasonal malaria chemoprevention (SMC) medicines every year.

Nigeriapaludismepublié 2024BMC health services researchPubMeddocument de 8 observations

This study did not observe mutations associated with the in vitro resistance in southeast Asia, such as Y493H, R539T, I543T, and C580Y.

Nigeriapaludismepublié 2021Malaria journalPubMeddocument de 5 observations

71,9 %The coinfection seroprevalence of chikungunya and malaria was 71.9% among 871 participants in three regions of Nigeria.

Nigeriachikungunya · paludismepublié 2022International journal of environmental research and public healthPubMeddocument de 6 observations

87 parasites/microl bloodParasite densities ranged from 87 to 36,209 parasites/microl blood in patients from Otu.

Nigeriapaludismepublié 2004African journal of medicine and medical scienceseurope_pmcdocument de 5 observations

20,5 %The proportion of parasite genotypes with two or more mutations was 20.5% in New Bussa.

Nigeriapaludismepublié 2021Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genPubMeddocument de 16 observations

23 %By 2013, 23% of reproductive aged women surveyed in Nigeria received sulfadoxine-pyrimethamine for malaria prevention in their last pregnancy of the past 5 years.

Nigeriapaludismeobservé 2013publié 2020Malawi medical journal : the journal of Medical Association of MalawiPubMeddocument de 2 observations

56 patientsGametocytaemia was detected in 56 patients (9%) after treatment among 612 children with uncomplicated Plasmodium falciparum malaria treated with amodiaquine.

Nigeriapaludismeobservé 2000 - 2006publié 2008Malaria journaleurope_pmcdocument de 7 observationsDOI 10.1186/1475-2875-7-169

64 %The prevalence of the worst-case scenario (fewer than four antenatal care visits and fewer than three intermittent preventive treatment with sulfadoxine-pyrimethamine doses) was 64.0% among pregnant women in the poorest wealth quintile in Nigeria.

Nigeriapaludismeobservé 2018publié 2026Malaria journalPubMeddocument de 9 observations

97,7 %Insecticide-treated net (ITN) ownership was 97.7% among rural households in Nigeria according to the 2021 Malaria Indicator Survey.

Nigeriapaludismeobservé 2021publié 2025BMC public healthPubMeddocument de 4 observations

3,6 odds_ratioLow-income households in rural Nigeria had 3.6 times higher odds of insecticide-treated net (ITN) use compared to higher-income households, according to the 2021 Malaria Indicator Survey.

Nigeriapaludismeobservé 2021publié 2025BMC public healthPubMeddocument de 4 observations

117 asexual forms/microlThe recrudescent parasitaemia had a geometric mean of 117 asexual forms/microl with a range of 40–9756, significantly lower than the primary infection geometric mean of 1112 (30–25,592) asexual forms/microl.

Nigeriapaludismepublié 2003Annals of tropical medicine and parasitologyeurope_pmcdocument de 4 observations

25,62 hoursMean parasite clearance time for the per-protocol population was 25.62 hours.

Nigeriapaludismepublié 2008Malaria journaleurope_pmcdocument de 10 observationsDOI 10.1186/1475-2875-7-246

0,8 µmol/litreThe IC99 of quinine against Nigerian Plasmodium falciparum isolates was 0.8 µmol per litre.

Nigeriapaludismepublié 1988Transactions of the Royal Society of Tropical Medicine and HygieneOpenAlexdocument de 5 observations

1,7 odds_ratioIn adjusted analyses, microscopy detectable gametocytemia at enrolment was associated with an increase in the odds of IgG seropositivity to Pf s230c (OR 1.70 [95% CI 1.10, 2.62], p = 0.017).

Nigeriapaludismepublié 2022Frontiers in cellular and infection microbiologyeurope_pmcdocument de 7 observations

57,1 %Women with only primary education had a malaria prevalence of 57.1%.

Nigeriapaludismepublié 2022African health sciencesPubMeddocument de 22 observations

2,86 cmMean spleen length was 2.86 ± 0.9 cm in children with asymptomatic malaria parasitaemia.

Nigeriapaludismepublié 2020Annals of global healthPubMeddocument de 9 observations

61,9 %The malaria-specific service readiness index was 61.9% among Primary Health Centres in Ekiti State.

Nigeriapaludismeobservé 2020publié 2022The Pan African medical journalPubMeddocument de 5 observations

The R21/Matrix-M vaccine has significantly reduced incident malaria in children aged 3–36 months.

Nigeriapaludismepublié 2025BMC public healthPubMeddocument de 8 observations

97,1 %The sensitivity of the DLM assay for Plasmodium falciparum detection in febrile Nigerian patients was 97.1%.

Nigeriapaludismepublié 2015Journal of clinical microbiologyeurope_pmcdocument de 6 observations

23,42 %The overall prevalence of malaria was 23.42% among 316 sampled mothers in Port Harcourt, Nigeria.

Nigeriapaludismepublié 2023Journal of vector borne diseasesPubMeddocument de 8 observations

3,2 %Among Plasmodium falciparum isolates from Lagos, Nigeria, mutations were observed at codon D1246Y in 3.2%.

Nigeriapaludismepublié 2026Biochemical geneticsPubMeddocument de 16 observations

51 482 cases_per_monthThe SARIMA model forecasted average monthly malaria cases of 51,482 in Nasarawa for the period 2025–2026.

Nigeriapaludismeobservé 2025-2026publié 2026PloS onePubMeddocument de 8 observations

20,2 %The Malaria Atlas Project projected a malaria prevalence of 20.2% during the dry season in the study area.

Nigeriapaludismeobservé dry seasonpublié 2020Malaria journalPubMeddocument de 6 observations

2 patientsTwo patients treated with halofantrine suffered recrudescent infections after treatment.

Nigeriapaludismepublié 1997Experimental parasitologyeurope_pmcdocument de 6 observations

78,2 %The prevalence of intermittent preventive treatment of malaria in pregnancy (IPTp) was 78.2% in the North West geopolitical zone of Nigeria.

Nigeriapaludismeobservé 2016-17publié 2021PloS oneeurope_pmcdocument de 14 observationsDOI 10.1371/journal.pone.0254475

Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.